Advances in high-throughput technologies allow for measurements of many types of omics data, yet the meaningful integration of several different data types remains a significant challenge. Another important and difficult problem is the discovery of molecular disease subtypes characterized by relevant clinical differences, such as survival. Here we present a novel approach, called perturbation clustering for data integration and disease subtyping (PINS), which is able to address both challenges. The framework has been validated on thousands of cancer samples, using gene expression, DNA methylation, noncoding microRNA, and copy number variation data available from the Gene Expression Omnibus, the Broad Institute, The Cancer Genome Atlas (TCGA...
With the rapid advancement of high-throughput technologies, a large amount of high-dimensional data ...
Abstract Background Patient subgroups are important for easily understanding a disease and for provi...
Cancer is a collection of genetic diseases, with large phenotypic differences and genetic heterogene...
BackgroundComprehensive molecular profiling has revealed somatic variations in cancer at genomic, ep...
The use of genome-wide data in cancer research, for the identification of groups of patients with si...
Identification and prediction of cancer subtypes are important parts in the development towards pers...
Motivation: One of the most important research areas in personalized medicine is the discovery of di...
Abstract Background The Cancer Genome Atlas (TCGA) has collected transcriptome, genome and epigenome...
Cancer is a genetic disease comprising multiple subtypes that have distinct molecular characteristic...
Molecular disease subtype discovery from omics data is an important research problem in precision me...
Motivation: Subtyping cancer is key to an improved and more personalized prognosis/treatment. The in...
Integrative analyses of high-throughput 'omic data, such as DNA methylation, DNA copy number alterat...
International audienceBackground: Facing the diversity of omics data and the difficulty of selecting...
Background Breast cancer is a heterogeneous disease at the clinical and molecular level. In this stu...
With the rapid advancement of high-throughput technologies, a large amount of high-dimensional data ...
Abstract Background Patient subgroups are important for easily understanding a disease and for provi...
Cancer is a collection of genetic diseases, with large phenotypic differences and genetic heterogene...
BackgroundComprehensive molecular profiling has revealed somatic variations in cancer at genomic, ep...
The use of genome-wide data in cancer research, for the identification of groups of patients with si...
Identification and prediction of cancer subtypes are important parts in the development towards pers...
Motivation: One of the most important research areas in personalized medicine is the discovery of di...
Abstract Background The Cancer Genome Atlas (TCGA) has collected transcriptome, genome and epigenome...
Cancer is a genetic disease comprising multiple subtypes that have distinct molecular characteristic...
Molecular disease subtype discovery from omics data is an important research problem in precision me...
Motivation: Subtyping cancer is key to an improved and more personalized prognosis/treatment. The in...
Integrative analyses of high-throughput 'omic data, such as DNA methylation, DNA copy number alterat...
International audienceBackground: Facing the diversity of omics data and the difficulty of selecting...
Background Breast cancer is a heterogeneous disease at the clinical and molecular level. In this stu...
With the rapid advancement of high-throughput technologies, a large amount of high-dimensional data ...
Abstract Background Patient subgroups are important for easily understanding a disease and for provi...
Cancer is a collection of genetic diseases, with large phenotypic differences and genetic heterogene...